N. Bleehen

发表

Theoretical Analysis and Clinical Demonstration of the Effect of Power Pattern Control Using the Annular Phased-Array Hyperthermia System

V. Sathiaseelan, M. Iskander, G. Howard, 1986 .

A microcomputer controlled, local hyperthermia system for uniform tumour heating in unanaesthetized mice.

N. Bleehen, M. Walton, D. Cattermole, 1989, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Hyperthermia in the treatment of cancer.

S. B. Field, N. Bleehen, 1979, Cancer treatment reviews.

A thermocouple for measuring temperature in biological material heated by microwaves at 2.45 GHz.

R J Sheppard, E H Grant, E. Grant, 1980, The British journal of radiology.

RF coils for combined MR and hyperthermia studies: II. MR coil as an hyperthermic applicator.

L. Hall, N. Bleehen, R. Jayasundar, 2001, Magnetic resonance imaging.

The dielectric properties of normal and tumour mouse tissue between 50 MHz and 10 GHz.

E. Grant, R. Sheppard, N. Bleehen, 1983, The British journal of radiology.

A broad band microwave applicator for heating tumours.

E. Grant, R. Sheppard, N. Bleehen, 1980, The British journal of radiology.

A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party.

N. Bleehen, S. Stenning, S. Stenning, 1991, British Journal of Cancer.

Resistance modification by PSC-833, a novel non-immunosuppressive cyclosporin A

N. Bleehen, P. Twentyman, 1991 .

Resistance modification by PSC-833, a novel non-immunosuppressive cyclosporin [corrected].

N. Bleehen, P. Twentyman, 1991, European journal of cancer.

A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytoma.

W. Lewin, N. Bleehen, C. Wiltshire, 1981, British Journal of Cancer.

Studies on high grade cerebral gliomas.

N. Bleehen, 1990, International journal of radiation oncology, biology, physics.

Cell-cell contact affects cellular sensitivity to hyperthermia.

N. Bleehen, J. Dobrucki, 1985, British Journal of Cancer.

A medical research council randomized trial in patients with primary cerebral non‐Hodgkin lymphoma

P. Lantos, A. Gregor, N. Bleehen, 2000, Cancer.

A record system for carcinoma of the larynx and hypopharynx designed for computer analysis.

N. Bleehen, D. Mackinnon, M. Buckley-Sharp, 1970, The Journal of laryngology and otology.

An overview of published results from randomized studies of nitrosoureas in primary high grade malignant glioma.

N. Bleehen, S. Stenning, L. Freedman, 1987, British Journal of Cancer.

Interaction of ICRF 159 with radiation, and its effect on sub-lethal and potentially lethal radiation damage in vitro.

I. Taylor, N. Bleehen, 1977, British Journal of Cancer.

The sensitivity to cytotoxic agents of the EMT6 tumor in vivo. Comparative response of lung nodules in rapid expotential growth and of the solid flank tumour.

N. Bleehen, P. Twentyman, 1976, British Journal of Cancer.

Changes in sensitivity to cytotoxic agents occurring during the life history of monolayer cultures of a mouse tumour cell line.

N. Bleehen, P. Twentyman, 1975, British Journal of Cancer.

Studies of "potentially lethal damage" in EMT6 mouse tumour cells treated with bleomycin either in vitro or in vivo.

N. Bleehen, P. Twentyman, 1975, British Journal of Cancer.

Changes in sensitivity to radiation and to blemycin occurring during the life history of monolayer cultures of a mouse tumour cell line.

N. Bleehen, P. Twentyman, 1975, British Journal of Cancer.

CHANGES IN CELL PROLIFERATION KINETICS OCCURRING DURING THE LIFE HISTORY OF MONOLAYER CULTURES OF A MOUSE TUMOUR CELL LINE

N. Bleehen, N. Bleehen, J. Watson, 1975, Cell and tissue kinetics.

The sensitivity to bleomycin of a solid mouse tumour at different stages of growth.

N. Bleehen, P. Twentyman, 1974, British Journal of Cancer.

The Sensitivity of Cells in Exponential and Stationary Phases of Growth to Bleomycin and to 1,3-bis(2-chloroethyl)-1-Nitrosourea

N. Bleehen, P. Twentyman, 1973, British Journal of Cancer.

A simplified technique for measurement of blood-brain barrier permeability using CT: Preliminary results of the effect of RMP-7

K. Miles, N. Bleehen, P. Bearcroft, 1996 .

Pharmacokinetics of carboplatin administered in combination with the bradykinin agonist Cereport (RMP-7) for the treatment of brain tumours

A. Boddy, N. Bleehen, M. Lind, 2000, Cancer Chemotherapy and Pharmacology.

The feasibility of using glycosylated recombinant human granulocyte colonystimulating factor (G-CSF) to increase the planned dose intensity of doxorubicin; cyclophosphamide and etoposide (ACE) in the treatment of small cell lung cancer

D. Girling, D. Machin, N. Bleehen, 1995 .

Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme

A. Taghian, N. Bleehen, F. S. Pardo, 1993 .

Radiotherapy for lung cancer.

N. Bleehen, J. Cox, J. Cox, 1985, International journal of radiation oncology, biology, physics.

p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus.

P. Ganly, P. Hasleton, N. Bleehen, 1992, Oncogene.

Radiotherapy for small cell lung cancer.

N. Bleehen, 1986, Chest.

Insulin-like growth factor (IGF) and IGF binding proteins in growth hormone dysregulation and abnormal glucose tolerance in small cell lung cancer patients.

N. Bleehen, P. Clark, P. Clark, 1995, European journal of cancer.

Small cell lung carcinoma. A phase II evaluation of r‐interferon‐γ

N. Bleehen, A. Galazka, H. F. Newman, 1987, Cancer.

The effects of anesthesia and physical restraint on intra- and extracellular tumor pH, tumor temperature and bioenergetics in murine RIF-1 tumors.

L. Hall, N. Bleehen, R. Jayasundar, 1997, Magnetic resonance imaging.

Comparison of pH measurements made using 31P NMR and a fibreoptic pH meter

L. Hall, N. Bleehen, R. Jayasundar, 1992, NMR in biomedicine.

Expression of insulinlike growth factor (IGF) and IGF-binding protein genes in human lung tumor cell lines.

N. Bleehen, J. Schwander, J. Mitchell, 1992, Journal of the National Cancer Institute.

Etoposide-induced cell cycle delay and arrest-dependent modulation of DNA topoisomerase II in small-cell lung cancer cells.

N. Bleehen, N. Bleehen, T. Gottlieb, 1994, British Journal of Cancer.

Report on the 3rd IASLC Lung Tumour Biology Workshop held at Robinson College, Cambridge 6–9 August 1990

N. Bleehen, P. Rabbitts, J. G. Reeve, 1991 .

Summary

S. Stewart, N. Bleehen, J. Hansen, 1966, National Institute Economic Review.

O6-methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma.

G. Rustin, N. Bleehen, E. Newlands, 1998, British Journal of Cancer.

Role of radiation therapy in small cell anaplastic carcinoma of the lung.

R. Wittes, P. Bunn, N. Bleehen, 1983, Cancer treatment reports.

Quantification of two aromatic amine mutagens, PBTA-1 and PBTA-2, in the yodo river system.

N. Bleehen, P. Workman, R. White, 1999, Environmental health perspectives.

Postoperative adjuvant treatments for non-small cell lung cancers: a consensus report

D. Ettinger, J. Jett, P. Houtte, 1991 .

Derivation and preliminary characterisation of adriamycin resistant lines of human lung cancer cells.

N. Bleehen, N. Fox, P. Twentyman, 1986, British Journal of Cancer.

Drug resistance in human lung cancer cell lines: cross-resistance studies and effects of the calcium transport blocker, verapamil.

N. Bleehen, N. Fox, P. Twentyman, 1986, International journal of radiation oncology, biology, physics.

Diminished Expression of Insulin-like Growth Factor (IGF) Binding Protein-5 and Activation of IGF-I-mediated Autocrine Growth in Simian Virus 40-transformed Human Fibroblasts (*)

N. Bleehen, J. Xiong, A. Guadaño, 1995, The Journal of Biological Chemistry.

Production of neuromedin B and neuromedin B gene expression in human lung tumor cell lines.

N. Bleehen, S. Bloom, E. Spindel, 1991, Cancer research.

The action of insulin in the isolated rat heart

N. Bleehen, R. Fisher, 1954, The Journal of physiology.

Chapter 13 Identification of antigenic phenotypes characterising lung tumour cell lines in vitro

N. Bleehen, P. Twentyman, J. Shaw, 1988 .

Neuroendocrine differentiation and clinical behaviour in non-small cell lung tumours.

S. Stewart, N. Bleehen, S. Stenning, 1991, British Journal of Cancer.

Neuron specific enolase expression in carcinoma of the lung.

N. Bleehen, J. Stewart, P. Twentyman, 1986, British Journal of Cancer.

31P NMR spectral editing technique for blood with short T2 values

L. Hall, N. Bleehen, R. Jayasundar, 1989 .

Spectral editing techniques for 31p NMR spectroscopy of blood

L. Hall, N. Bleehen, R. Jayasundar, 1989, Magnetic resonance in medicine.

Primary lymphoma of the central nervous system: experience at Addenbrooke's Hospital, Cambridge.

C. Freer, N. Bleehen, M. Ashby, 1988, Clinical radiology.

Paraffin wax‐embedded material as a source of DNA for the detection of somatic genetic changes

P. Ganly, P. Hasleton, N. Bleehen, 1993, The Journal of pathology.

A Pilot Study of Idiotypic Vaccination for Follicular B-cell Lymphoma Using a Genetic Approach. University of Bristol, Bristol, United Kingdom

N. Bleehen, G. Winter, S. Russell, 1997 .

The effect of bleomycin and radiation in combination on bacteria and mammalian cells in culture.

N. Bleehen, P. Twentyman, N. Gillies, 1974, The British journal of radiology.

Phase II study of carboplatin and adriamycin as second line chemotherapy in small cell lung cancer.

N. Bleehen, R. Osborne, T. Maughan, 1993, Clinical oncology (Royal College of Radiologists (Great Britain)).

Monoclonal‐antibody‐defined human lung tumour cell‐surface antigens

N. Bleehen, J. Stewart, P. Twentyman, 1985, International journal of cancer.

A phase II study of CCNU with benznidazole for metastatic malignant melanoma.

N. Bleehen, J. Roberts, H. F. Newman, 1986, International journal of radiation oncology, biology, physics.

Radiosensitizers and Lung Cancer: Basic and Clinical Aspects

N. Bleehen, 1986 .

Benznidazole with CCNU: a clinical phase I toxicity study.

N. Bleehen, J. Roberts, 1985, International journal of radiation oncology, biology, physics.

The penetration of misonidazole and desmethylmisonidazole into brain tumours and other central nervous system tissues in man.

N. Bleehen, P. Workman, R. Grant, 1983, The British journal of radiology.

Hypoxic Cell Sensitizers in the Management of Brain Tumours

N. Bleehen, 1991 .

Monitoring salivary misonidazole in man: a possible alternative to plasma monitoring.

N. Bleehen, P. Workman, C. Wiltshire, 1978, British Journal of Cancer.

Clinical studies with misonidazole.

N. Bleehen, P. Workman, C. Wiltshire, 1978, The British journal of cancer. Supplement.

Characterisation of VP-16-induced DNA cleavage in oestrogen-stimulated human breast cancer cells.

R. Epstein, N. Bleehen, P. Smith, 1988, British Journal of Cancer.

A phase I study of the combination of two hypoxic cell radiosensitizers, Ro 03-8799 and SR-2508: toxicity and pharmacokinetics.

N. Bleehen, P. Workman, H. F. Newman, 1986, International journal of radiation oncology, biology, physics.

Lack of stereoselectivity in the pharmacokinetics and metabolism of the radiosensitizer Ro 03-8799 in man

N. Bleehen, P. Workman, C. E. Smithen, 2004, Cancer Chemotherapy and Pharmacology.

The combination of multiple doses of etanidazole and pimonidazole in 48 patients: a toxicity and pharmacokinetic study.

N. Bleehen, P. Workman, T. Maughan, 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A multiple dose study of the combined radiosensitizers Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole).

N. Bleehen, P. Workman, T. Maughan, 1989, International journal of radiation oncology, biology, physics.

Vinblastine Sulphate in the Treatment of Malignant Disease

N. Bleehen, A. Jelliffe, 1965, British Journal of Cancer.

Radiotherapy in high grade gliomas

N. Bleehen, S. Stenning, 1989, British Journal of Cancer.

Lung cancer--still a long road ahead.

N. Bleehen, 1990, British Journal of Cancer.

Phase II trials of flavone acetic acid in advanced malignant melanoma and colorectal carcinoma.

D. Kerr, G. Rustin, N. Bleehen, 1989, British Journal of Cancer.

The role of radiotherapy in the management of small cell bronchogenic carcinoma.

N. Bleehen, D. Jones, 1985, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

The treatment of inoperable lung cancer by radiotherapy and chemotherapy.

N. Bleehen, 1980, International journal of radiation oncology, biology, physics.

IGFBP-2: an important regulator of insulin-like growth factor action in human lung tumours?

N. Bleehen, J. Schwander, J. G. Reeve, 1993, Growth regulation.

Ethmoid sinus cancer.

N. Bleehen, 1972, JAMA.

Neurotensin in human small cell lung carcinoma.

P. Emson, M. Goedert, N. Bleehen, 1985, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Neurotensin in human small cell lung carcinoma.

P. Emson, M. Goedert, N. Bleehen, 1984, British Journal of Cancer.

Pharmacokinetics of BW12C and mitomycin C, given in combination in a phase 1 study in patients with advanced gastrointestinal cancer

N. Bleehen, P. Workman, J. Ramsay, 1993, Cancer Chemotherapy and Pharmacology.

International Clinical Trials in Radiation Oncology. Chemical modifiers.

H. Bartelink, T. Phillips, N. Bleehen, 1988, International journal of radiation oncology, biology, physics.

Immunohistochemical techniques in the early screening of monoclonal antibodies to human colonic epithelium

N. Bleehen, R. Grant, F. Takei, 1982, British Journal of Cancer.

The role of dexamethasone in the modification of misonidazole pharmacokinetics.

N. Bleehen, P. Workman, M. Walton, 1983, British Journal of Cancer.

Phenytoin shortens the half-life of the hypoxic cell radiosensitizer misonidazole in man: implications for possible reduced toxicity.

N. Bleehen, P. Workman, C. Wiltshire, 1980, British Journal of Cancer.

The Cambridge glioma trial of misonidazole and radiation therapy with associated pharmacokinetic studies.

N. Bleehen, 1980, Cancer clinical trials.

The neurotoxicity of misonidazole: pooling of data from five centres.

T. Phillips, N. Bleehen, T. Wasserman, 1978, British Journal of Radiology.

Production of immunoreactive insulin-like growth factor-I (IGF-I) and IGF-I binding proteins by human lung tumours.

N. Bleehen, N. Bleehen, J. A. Payne, 1990, British Journal of Cancer.

Management of small cell cancer: radiotherapy.

N. Bleehen, 1984, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Early Clinical Experience with Bleomycin in the United Kingdom in Series of 105 Patients

N. Bleehen, I. Todd, D. Harrison, 1972, British medical journal.

Precipitation by fatty food of systemic disturbance from argentaffinoma.

N. Bleehen, 1955, Lancet.

A pilot study of idiotypic vaccination for follicular B-cell lymphoma using a genetic approach. CRC NO: 92/33. Protocol NO: PH1/027.

W. Ouwehand, R. Marcus, N. Bleehen, 1997, Human gene therapy.

Medical Research Council (MRC) randomised trial of adjuvant chemotherapy in high grade glioma (HGG)- BR05.

P. Lantos, N. Bleehen, F. Senanayake, 1998 .

Radioactive yttrium in the treatment of rheumatoid knee effusions. Preliminary evaluation.

N. Bleehen, F. Bruckner, J. Bridgman, 1971, Annals of the rheumatic diseases.

Irradiation of the synovium in the treatment of rheumatoid arthritis.

N. Bleehen, F. Bruckner, J. Bridgman, 1973, The Quarterly journal of medicine.

An investigation of radioactive yttrium (90Y) for the treatment of chronic knee effusions.

N. Bleehen, J. Bridgman, H. Prichard, 1970, The British journal of radiology.

Radiobiology in Radiotherapy

N. Bleehen, 2011, Springer London.

Clinical Hyperthermia: Methods and Results

G. Howard, N. Bleehen, 1988 .

Hyperthermia and radiation in the management of canine tumours

N. Bleehen, J. Thompson, L. Owen, 1987 .

Insights from radiation treatment for benign disease.

N. Bleehen, 1987, British medical journal.

The sensitivity to bleomycin of spleen colony forming units in the mouse.

N. Bleehen, P. Twentyman, 1973, British Journal of Cancer.

Phase I study of intravenous 4-hydroxyanisole.

P. Philip, G. Rustin, A. Lamont, 1992, European journal of cancer.

Human blood group isoantigen expression on normal and malignant gastric epithelium studied with anti-A and anti-B monoclonal antibodies.

N. Bleehen, S. Sacks, D. Wight, 1983, Journal of the National Cancer Institute.

The role of microsomal enzyme inducers in the reduction of misonidazole neurotoxicity.

N. Bleehen, P. Workman, D. Jones, 1983, The British journal of radiology.

The expression of ABH and Y blood group antigens in benign and malignant breast tissue: the preservation of the H and Y antigens in malignant epithelium.

N. Bleehen, P. Vowden, E. Lennox, 1986, British Journal of Cancer.

Are blood group isoantigens lost from malignant prostatic epithelium? Immunohistochemical support for the preservation of the H isoantigen.

N. Bleehen, P. Vowden, E. Lennox, 1986, British Journal of Cancer.

Changes in sensitivity to radiation and ICRF 159 during the life of monolayer cultures of EMT6 tumour line.

I. Taylor, N. Bleehen, 1977, British Journal of Cancer.

A randomized study of CCNU with and without benznidazole in the treatment of recurrent grades 3 and 4 astrocytoma. Report to the Medical Research Council by the Brain Tumor Working Party.

N. Bleehen, S. Stenning, L. Freedman, 1989, International journal of radiation oncology, biology, physics.

Increased expression of human monocyte HLA-DR antigens and Fc gamma receptors in response to human interferon in vivo.

N. Bleehen, J. Rhodes, D. Jones, 1983, Clinical and experimental immunology.

The pharmacokinetics of misonidazole in the dog.

N. Bleehen, P. Workman, R. White, 1979, European journal of cancer.

Cytogenetic abnormalities in human small cell lung carcinoma: cell lines characterized for myc gene amplification.

N. Bleehen, P. Rabbitts, J. Waters, 1988, Cancer genetics and cytogenetics.

Establishment and characterisation of cell lines from patients with lung cancer (predominantly small cell carcinoma).

N. Bleehen, P. Workman, N. Fox, 1985, British Journal of Cancer.

Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.

N. Bleehen, J. Schwander, J. G. Reeve, 1993, Cancer research.

MEDICAL RESEARCH COUNCIL STUDY ON CHEMOTHERAPY IN ADVANCED OVARIAN CANCER

N. Bleehen, 1981 .

A preliminary trial of a novel form of active immunotherapy in squamous cell carcinoma of the lung.

K. Sikora, N. Bleehen, P. Lachmann, 1985, British Journal of Cancer.

An unusually proximal deletion on the short arm of chromosome 3 in a patient with small cell lung cancer.

J. Bergh, N. Bleehen, P. Rabbitts, 1991, Genomics.

The effect of hyperthermia and radiation on small bowel permeability using 51Cr EDTA and 14C mannitol in man.

G. Howard, N. Bleehen, R. Coltart, 1988, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Response of EMT6 multicellular tumour spheroids to hyperthermia and cytotoxic drugs.

N. Bleehen, J. Morgan, 1981, British Journal of Cancer.

Chapter 21 Expression of monoclonal antibody-defined lung tumour antigens in drug resistant lung tumour cell lines

N. Bleehen, P. Twentyman, J. Shaw, 1988 .

Final report of the general clinical results of the British Institute of Radiology fractionation study of 3F/wk versus 5F/wk in radiotherapy of carcinoma of the laryngo-pharynx.

J. Haybittle, J. Fowler, N. Bleehen, 1990, The British journal of radiology.

Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma.

N. Bleehen, G. Rustin, N. Bleehen, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Expression of apoptosis-regulatory genes in lung tumour cell lines: relationship to p53 expression and relevance to acquired drug resistance.

N. Bleehen, N. Bleehen, J. Xiong, 1996, British Journal of Cancer.

A Cancer Research Campaign (CRC) phase II trial of CB10-277 given by 24 hour infusion for malignant melanoma.

N. Bleehen, S. Kaye, P. Harper, 1994, British Journal of Cancer.

The effects of alpha and gamma interferons on human lung cancer cells grown in vitro or as xenografts in nude mice.

N. Bleehen, P. Workman, P. Twentyman, 1985, British Journal of Cancer.

Regional hyperthermia for extensive pelvic tumours using an annular phased array applicator: a feasibility study.

A K Dixon, G A King, V Sathiaseelan, 1986, The British journal of radiology.

Experimental and Clinical Aspects of Hyperthermia Applied to the Treatment of Cancer with Special Reference to the Role of Ultrasonic and Microwave Heating

N. Bleehen, I. Har-Kedar, 1976 .

Radiation Oncology—Rationale, Technique, Results

N. Bleehen, 1980, British Journal of Cancer.

Interaction of hyperthermia and the hypoxic cell sensitizer Ro-07-0582 on the EMT6 mouse tumour.

N. Bleehen, D. Honess, J. Morgan, 1977, British Journal of Cancer.

Enhancement of thermal killing by polyamines V. The response of EMT6 multicellular tumour spheroids versus monolayer cells.

N. Bleehen, E. Ben-hur, J. Shaw, 1983, British Journal of Cancer.

Hyperthermia and Cancer: Human Clinical Trial Experience

N. Bleehen, 1984 .

Hyperthermia – a Treatment Method for Cancer?

N. Bleehen, 1981, Journal of the Royal Society of Medicine.

Hyperthermia in the treatment of cancer.

N. Bleehen, N M Bleehen, 1982, The British journal of cancer. Supplement.

RF coils for combined MR and hyperthermia studies: I. Hyperthermia applicator as an MR coil.

L. Hall, N. Bleehen, R. Jayasundar, 2001, Magnetic resonance imaging.

Human lymphoblastoid interferon in the treatment of small cell lung cancer.

A. Dixon, N. Bleehen, J. Walker, 1983, British Journal of Cancer.

Interaction of bleomycin, hyperthermia and a calmodulin inhibitor (trifluoperazine) in mouse tumor cells.

N. Bleehen, P. Smith, J. Mircheva, 1986, International journal of radiation oncology, biology, physics.

Interaction of bleomycin, hyperthermia and a calmodulin inhibitor (trifluoperazine) in mouse tumour cells: I. In vitro cytotoxicity.

N. Bleehen, P. Smith, J. Mircheva, 1986, British Journal of Cancer.

Phase I and pharmacokinetic study of DACA (XR5000): a novel inhibitor of topoisomerase I and II

P. Beale, N. Bleehen, P. Vasey, 1999, British Journal of Cancer.

Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme.

P. Okunieff, A. Taghian, N. Bleehen, 1992, International journal of radiation oncology, biology, physics.

Can long-term survival be improved in patients with small-cell lung cancer (SCLC) and good performance status? Medical Research Council Lung Cancer Working Party.

R. Stephens, A. Gregor, D. Machin, 1994, British Journal of Cancer.

A Medical Research Council phase II trial of alternating chemotherapy and radiotherapy in small-cell lung cancer. The Medical Research Council Lung Cancer Working Party.

R. Stephens, A. Gregor, D. Machin, 1991, British Journal of Cancer.

Consensus report on combined radiotherapy and chemotherapy modalities in lung cancer.

J. Goldie, R. Souhami, R. Arriagada, 1988, Antibiotics and chemotherapy.

The prediction of invasive potential in superficial transitional cell carcinoma of the bladder.

N. Bleehen, J. Anderson, E. Lennox, 1982, British journal of urology.

Interaction of bleomycin, hyperthermia and a calmodulin inhibitor (trifluoperazine) in mouse tumour cells: II. DNA damage, repair and chromatin changes.

N. Bleehen, J. Mircheva, P. Smith, 1986, British Journal of Cancer.

In vivo-in vitro clonogenic assays in a human tumour xenograft with a high plating efficiency.

N. Bleehen, H. Warenius, 1982, British Journal of Cancer.

The response of a human tumour xenograft to chemotherapy: intrinsic variation between tumours and its significance in planning experiments.

N. Bleehen, L. Freedman, H. Warenius, 1980, The British journal of cancer. Supplement.

Growth inhibition by neurotensin in small cell lung cancer cell lines in vitro

N. Bleehen, J. Shaw, J. G. Reeve, 1988 .

Razoxane-induced polyploidy.

I. Taylor, N. Bleehen, 1978, British Journal of Cancer.

Brampton, M, Stevens MFG. Cancer Research Campaign phase-II trial of temozolomide in malignant melanoma

G. Rustin, N. Bleehen, E. Newlands, 1995 .

Attempted targeting of a monoclonal antibody in a human tumour xenograft system.

C. Milstein, N. Bleehen, G. Galfrè, 1981, European journal of cancer & clinical oncology.

Response of 145 spontaneous canine head and neck tumours to radiation versus radiation plus microwave hyperthermia: results of a randomized phase III clinical study.

N. Bleehen, S. Stenning, N M Bleehen, 1995, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Clinical pharmacokinetics of oral CCNU (Lomustine)

N. Bleehen, P. Workman, F. Y. Lee, 2004, Cancer Chemotherapy and Pharmacology.

Pharmacokinetic and Therapeutic Studies with Misonidazole and Desmethylmisonidazole in Man

N. Bleehen, 1982 .

Management of CNS metastases in small cell lung cancer: a consensus report

D. Ettinger, H. Earl, P. Postmus, 1989 .

Flow cytometric and immunohistochemical analysis of p62c-myc oncoprotein in the bronchial epithelium of lung cancer patients.

N. Bleehen, B. Wilson, V. Sundaresan, 1991, Anticancer research.

Effect of cell density on intracellular adriamycin concentration and cytotoxicity in exponential and plateau phase EMT6 cells.

N. Bleehen, J. Watson, S. H. Chambers, 1984, British Journal of Cancer.

Clinical experience in the combination of hyperthermia with chemotherapy or radiotherapy.

G. Howard, N. Bleehen, 1988, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Thyroid blood group isoantigen expression: a parallel with ABH isoantigen expression in the distal colon.

N. Bleehen, P. Vowden, E. Lennox, 1986, British Journal of Cancer.

A phase I study of the combined hypoxic cell radiosensitizers, Ro 03-8799 and SR 2508: a preliminary report of single-dose toxicity, pharmacokinetics and tumour concentrations.

N. Bleehen, P. Workman, H. F. Newman, 1986, The British journal of radiology.

Combined radiation and chemotherapy for unresectable non-small cell lung carcinoma.

E. Shaw, N. Bleehen, J. Cox, 1994, Lung cancer.

Radiation therapy planning

J. Haybittle, N. Bleehen, E. Glatstein, 1983 .

Oncogene amplification and chromosomal abnormalities in small cell lung cancer

N. Bleehen, P. Rabbitts, P. Twentyman, 1987, Journal of cellular biochemistry.

Radiotherapy, hyperthermia, and photodynamic therapy for central nervous system tumors.

N. Bleehen, J. Ford, 1993, Current Opinion in Oncology.

A phase II evaluation of human lymphoblastoid interferon (Wellferon) in relapsed high grade malignant glioma

N. Bleehen, S. Stenning, T. Priestman, 1993 .

A perfused biological phantom and tumour model.

V. Sathiaseelan, G. Howard, N. Bleehen, 1985, British Journal of Cancer.

[D-Arg1, D-Phe5, D-Trp7,9, Leu11] substance P induces apoptosis in lung cancer cell lines in vitro.

N. Bleehen, J. G. Reeve, 1994, Biochemical and biophysical research communications.

Interaction of bleomycin, hyperthermia and a calmodulin inhibitor (trifluoperazine) in mouse tumour cells: II. DNA damage, repair and chromatin changes.

N. Bleehen, D. Tenenbaum, J. Mircheva, 1986, British Journal of Cancer.

Scheduled and unscheduled combination chemotherapy in the treatment of squamous cell lung cancer (cyclophosphamide, adriamycin, vincristine and bleomycin, with and without cis-platinum).

K. Sikora, N. Bleehen, R. Grant, 1983, Anticancer Research.

Hyperthermia in the treatment of cancer.

N. Bleehen, 1982, The British journal of cancer. Supplement.

A microcomputer-controlled microwave hyperthermia system

Vythialingam Sathiaseelan, I. Har-Kedar, G. C. W. Howard, 1983 .

Microwave hyperthermia in the treatment of spontaneous canine tumours: an analysis of treatment parameters and tumour response.

N. Bleehen, J. Thompson, N. Gorman, 1988, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Hyperthermia and radiation in the treatment of superficial malignancy: an analysis of treatment parameters, response and toxicity.

V. Sathiaseelan, G. Howard, N. Bleehen, 1987, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

An analysis of error in the retrieval of patient case note data

N. Bleehen, D. Mackinnon, M. Buckley-Sharp, 1970, The Journal of Laryngology & Otology.

Fundamental and Clinical Studies of Bleomycin

N. Bleehen, 1977, British Journal of Cancer.

Simultaneous evaluation of the effects of RF hyperthermia on the intra‐ and extracellular tumor pH

L. Hall, N. Bleehen, R. Jayasundar, 2000, Magnetic resonance in medicine.

Use of Different Outcome Measures in Randomised Studies of Malignant Glioma can Significantly Alter the Interpretation of Time to Progression: Reanalysis of the MRC BR2 Study

N. Bleehen, J. Chataway, S. Stenning, 1999, Journal of Neuro-Oncology.

Effects of calcium channel blockers on renal function in mice.

N. Bleehen, N. Bleehen, D. Honess, 1992, International journal of radiation oncology, biology, physics.

Monoclonal‐antibody‐defined human lung tumour cell‐surface antigens

N. Bleehen, P. Twentyman, J. G. Reeve, 1985, International journal of cancer.